Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 1;28(1):54-56.
doi: 10.5588/ijtld.23.0272.

Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013-2020

D Surie  1 , M K Sathyanarayanan  2 , J Lavanya  3 , J P Smith  1 , S K Shanmugam  2 , S Tamilzhalagan  2 , A Selvaraj  2 , G Ramesh  2 , S Tripathy  2   4 , S D Khaparde  5 , C S Ho  1 , P J Hall-Eidson  1 , U D K Ranganathan  2 , S Selvaraju  2 , P K Moonan  1
Affiliations

Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013-2020

D Surie et al. Int J Tuberc Lung Dis. .
No abstract available

PubMed Disclaimer

References

    1. Government of India, Ministry of Health and Family Welfare. National TB Elimination Programme Report, 2022 Delhi, India. GoI, 2023.
    1. Menzies NA, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health 2021;9(12):e1679–e1687. - PMC - PubMed
    1. Walker IF, et al. Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Eur Respir J 2019;54(1):1800353. - PubMed
    1. Tamilzhalagan S, et al. Whole-genome sequencing to identify missed rifampicin and isoniazid resistance among tuberculosis isolates–Chennai, India, 2013–2016. Front Microbiol 2021;12:720436. - PMC - PubMed
    1. World Health Organisation. Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis Geneva, Switzerland: WHO, 2018.

MeSH terms

Substances